Expiring federal contract
W81K0223P0126 — Sebia, INC.
Department of Defense · Defense Health Agency
- Contract / PIID
- W81K0223P0126
- Incumbent
- Sebia, INC.
- Incumbent UEI
- WKVRJJ6G6VB5
- Current end date
- September 30, 2027
- Potential total value
- $658,291
- Obligated
- $658,291
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Set-aside
- Full & Open
- Start date
- October 1, 2023
- Place of performance
- WA
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
REAGENTS AND VARIOUS SUPPLIES FOR USE WITH SEBIA CAPILLARYS 3 OCTA ANALYZER
Likely rebid window (estimate)
- Sources Sought / RFI: about Sep 2026 – Mar 2027 (6–12 months before the end date)
- RFP: about May 2027 – Jul 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Defense (NAICS 325413)
- FA283522P0005 — Quidelortho Sales Company, LLC · ends December 31, 2026 · $124K
- W81K0025CA001 — Nova Biomedical Corp · ends December 31, 2026 · $336K
- FA486123C0025 — Biomerieux INC · ends January 14, 2027 · $256K
- N6817123P6017 — Abbott Laboratories, Sa · ends January 28, 2027 · $128K
- W91YTZ23C0003 — Beckman Coulter, INC · ends February 6, 2027 · $542K
- HT001426FE021 — One Lambda, INC. · ends February 9, 2027 · $847K
- HT001424P0068 — Biocare Medical LLC · ends March 24, 2027 · $225K
- W81K0024P0021 — Quidelortho Sales Company, LLC · ends March 31, 2027 · $528K
- W91YTZ24P0015 — Roche Diagnostics Corporation · ends April 14, 2027 · $379K
- N3239826P0015 — Maxim Biomedical, INC · ends May 18, 2027 · $155K